Table 3.
APIs | Polymer Carriers | Miscibility Parameter(s) Investigated | Force Field | Brief Simulation Overview 1 | Experimental Miscibility Comparison | Reference |
---|---|---|---|---|---|---|
Indomethacin | PEO, glucose, sucrose | δ 2 | COMPASS | 2 ns NVT 3/NPT 4 equilibration, 200–500 ps NVT production (298 K, 1 fs/step) | PEO (miscible), glucose (immiscible), sucrose (borderline) predictions in agreement with thermal analysis experiments. | [57] |
Artemisinin | PVP/PEG | COMPASS | 500 ps NPT equilibration, 200 ps production (298 K, 1 fs/step) | Predicted PVP and PEG miscibility in agreement with observed drug dispersion from thermal analysis. | [62] | |
Gemcitabine | Chitosan | COMPASS | 200 ps NPT equilibration, 800 ps production (298 K, 1 fs/step) | N/A | [61] | |
Telaprevir | Cellulose derivatives | CHARMM | 50 ps NVE (0.5 fs/step), 5 ns NVT/NPT (310 K, 1 fs/step) equilibration, 40 ns NPT production (310 K, 1 fs/step) | N/A | [54] | |
Clonazepam, ibuprofen, fenofibrate, alprazolam | PVP–VA 64, HPMC, and Eudragit EPO | COMPASS | 2 ns NPT equilibration, 500 ps NVT production (298 K, 1 fs/step) | Predicted fenofibrate/PVP-VA 64 weaker intermolecular interactions in agreement with observed recrystallization during stability experiments. | [63] | |
Ibuprofen, carbamazepine | SOL/PEG | CHARMM | 2 ns NPT relaxation (393 K cooled to 298 K for ibuprofen, 474 K cooled to 298 K for carbamazepine, 10 K/step), 100 ps NPT equilibration/300 ps production at each temperature. | Both ibuprofen and carbamazepine predicted as miscible with SOL/PEG in agreement with observed single Tg values from DSC experiments. | [50] | |
6-Mercaptopurine | PLA, PEG-modified PLA | PCFF | 2 ns NPT dynamics (298 K, 1 fs/step) | N/A | [58] | |
Olmesartan medoxomil | PVP–VA 64, SOL | OPLS | 5 ns NPT dynamics (300 K, 1 fs/step) | Predicted high miscibility with PVP–VA 64 carrier reflected in crystallography and thermal analysis experiments. | [81] | |
Cyclosporin A | l/d–polylactide, chitosan, polyglycolic acid, PEG, cellulose | χ 5 | PCFF | 1.5 ns NPT dynamics (298 K) | N/A | [60] |
Indomethacin | PEG, PLA | COMPASS | 5 ps NVT equilibration at each temperature step (298 K heated to 500 K in three steps, then cooled back to 298 K in three steps). 30 ns equilibration at the last step. 1 ns NPT production (298 K, 1 fs/step) | Predicted significant miscibility (negative interaction parameters) for indomethacin with both PEG and PLA as carriers in agreement with encapsulation efficiency experiments. | [56] | |
Felodipine | HPMC | , | Amber/GLYCAM | 10 ns equilibration (500–700 K), then cooled to 200 K (0.03 K/ps). 30–100 ns production (298 K, 1 fs/step). | Predicted miscibility from solubility and interaction parameters at all HPMC concentrations in agreement with observed single Tg values from DSC. | [69] |
Indomethacin | PVP | , | Amber | 10 ns equilibration (600 K), then cooled to 200 K (0.03 K/ps). 100 ns production runs (298 K, 1 fs/step). | N/A | [68] |
Tacrine | Chitosan, PBCA | , | PCFF | 100 ps equilibration (300 K), 5 ns NPT (298 K, 1 fs/step) | N/A | [74] |
Simvastatin | PVP | , | PCFF | 5 ns NPT relaxation (600 K cooled to 200 K, 10 K/step, 1 fs/step). 400 ps NPT runs at each temperature. (1 fs/step) | Predicted miscibility from MD–based interaction parameter calculation in close agreement with measured value derived from melting point depression experiments. | [52] |
Aspirin, caffeine, carbamazepine, finasteride, flufenamic acid, flutamide, mefenamic acid, salicylamide, theophylline |
PVP–VA 64, poly (glycerol adipate) and derivatives | , | CHARMM | Iterate cell volume prior to arriving at target density. At each step of the cycle, minimization, then 200 ps NVT dynamics (700 K, 1 fs/step). Cell then underwent annealing from 750 K to 300 K (0.1 K/ps). Minimization then 10 ns NPT dynamics (300 K). | Predicted solubility and interaction parameters showed no correlation to measured miscibility limits. Opposite to experimental values, MD-derived FH interaction parameters for six of nine API–PGA polymers predicted complete miscibility. | [110] |
1 See reference for more simulation details, including specific software settings, force field parameters, API–polymer cell construction, energy minimization algorithms, thermostats/barostats algorithms, periodic boundary conditions, integrators, dispersion cutoff distances, and long-range electrostatic methods. 2 Solubility parameter (), 3 Canonical ensemble conserving substance (N), volume (V), and temperature (T). 4 Isothermal–isobaric ensemble conserving substance (N), pressure (P), and temperature (T). 5 Flory–Huggins interaction parameter (). N/A: Not Applicable; PEO: polyethylene oxide; PVP-VA 64: poly(vinylpyrrolidone-co-vinyl acetate) 64; SOL: Soluplus; PBCA: polybutylcyanoacrylate; Differential scanning calorimetry: DSC.